CLINICAL TRIALS PROFILE FOR NUTROPIN AQ NUSPIN
✉ Email this page to a colleague
All Clinical Trials for NUTROPIN AQ NUSPIN
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT01243892 ↗ | A Study to Evaluate Growth in Participants Treated With Somatropin (Nutropin) Using NuSpin Device | Terminated | Genentech, Inc. | 2010-11-01 | This is a Phase IV, open label, case-controlled, observational study to evaluate the age-adjusted cumulative height velocity in pre-pubertal isolated growth hormone deficient (IGHD) and idiopathic short stature (ISS) participants receiving daily doses of somatropin (recombinant human growth hormone [rhGH]; Nutropin) using NuSpin device compared to historical controls from the national cooperative growth study (NCGS). | |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for NUTROPIN AQ NUSPIN
Condition Name
Clinical Trial Locations for NUTROPIN AQ NUSPIN
Trials by Country
Clinical Trial Progress for NUTROPIN AQ NUSPIN
Clinical Trial Phase
Clinical Trial Sponsors for NUTROPIN AQ NUSPIN
Sponsor Name